Sofinnova Investments, Inc. Quant / Systematic

Location: Menlo Park, CA

CIK: 0001631134 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value: $1.106B (100.0% shares, 0.0% debt)

Holdings (72)

ASND Ascendis Pharma A/S 9.7%
Value $107M Shares 1,109,874 Share Price $96.32 Est. Cost/Share $69.98 Unrealized @ Report Date —
NTRA Natera 9.2%
Value $102M Shares 3,100,560 Share Price $32.80 * Est. Cost/Share $9.81 Unrealized @ Report Date +201.4%
— Amarin 7.1%
Value $78.96M Shares 5,208,305 Share Price $15.16 Est. Cost/Share $7.81 Unrealized @ Report Date —
— Nextcure, Inc 7.0%
Value $77.8M Shares 2,521,856 Share Price $30.85 Est. Cost/Share $14.98 Unrealized @ Report Date —
— Y-mAbs Therapeutics, Inc 5.0%
Value $54.84M Shares 2,104,278 Share Price $26.06 Est. Cost/Share $26.56 Unrealized @ Report Date —
— Spark Therapeutics 4.2%
Value $46.67M Shares 481,270 Share Price $96.98 Est. Cost/Share $66.59 Unrealized @ Report Date —
— Principia Biopharma 3.6%
Value $40.02M Shares 1,417,258 Share Price $28.24 Est. Cost/Share $28.92 Unrealized @ Report Date —
— ObsEva SA 3.6%
Value $39.56M Shares 4,749,623 Share Price $8.33 Est. Cost/Share $13.49 Unrealized @ Report Date —
CHRS Coherus BioSciences 3.5%
Value $39.17M Shares 1,933,221 Share Price $20.26 Est. Cost/Share $10.94 Unrealized @ Report Date +82.6%
— Merus N.V. 3.2%
Value $34.95M Shares 1,961,039 Share Price $17.82 Est. Cost/Share $18.53 Unrealized @ Report Date —
— Karuna Therapeutics, Inc. 2.6%
Value $28.22M Shares 1,729,352 Share Price $16.32 Est. Cost/Share $20.02 Unrealized @ Report Date —
— Health Care Select Sector SPDR 2.4%
Value $27.04M Shares 300,000 Share Price $90.13 Est. Cost/Share — Unrealized @ Report Date —
— Audentes Therapeutics 2.4%
Value $26.23M Shares 933,640 Share Price $28.09 Est. Cost/Share $30.05 Unrealized @ Report Date —
BMY Bristol-Myers Squibb Co 2.2%
Value $24.26M Shares 478,349 Share Price $50.71 * Est. Cost/Share $36.53 Unrealized @ Report Date +0.6%
— Allergan plc 2.0%
Value $22.62M Shares 134,433 Share Price $168.29 Est. Cost/Share $154.55 Unrealized @ Report Date —
VRTX Vertex Pharmaceuticals Inc 1.9%
Value $20.62M Shares 121,690 Share Price $169.41 * Est. Cost/Share $176.04 Unrealized @ Report Date +0.5%
AMGN Amgen Inc 1.6%
Value $17.86M Shares 92,300 Share Price $193.51 * Est. Cost/Share $158.01 Unrealized @ Report Date 0.0%
— Nucana Biomed Ltd 1.6%
Value $17.38M Shares 2,400,000 Share Price $7.24 Est. Cost/Share $19.00 Unrealized @ Report Date —
NBIX Neurocrine Biosciences Inc 1.6%
Value $17.27M Shares 191,679 Share Price $90.11 * Est. Cost/Share $89.01 Unrealized @ Report Date +5.0%
— Nucana Biomed Ltd 1.5%
Value $16.41M Shares 2,266,666 Share Price $7.24 Est. Cost/Share $15.80 Unrealized @ Report Date —
— Acceleron Pharma Inc 1.5%
Value $16.13M Shares 408,262 Share Price $39.51 Est. Cost/Share $40.44 Unrealized @ Report Date —
UTHR United Therapeutics Corp 1.4%
Value $15.47M Shares 194,014 Share Price $79.75 Est. Cost/Share $80.53 Unrealized @ Report Date 0.0%
PFE Pfizer Inc 1.3%
Value $14.75M Shares 410,607 Share Price $35.93 * Est. Cost/Share $27.02 Unrealized @ Report Date 0.0%
— Reata Pharmaceuticals Inc 1.1%
Value $11.94M Shares 148,669 Share Price $80.29 Est. Cost/Share $74.49 Unrealized @ Report Date —
— Reata Pharmaceuticals Inc 1.1%
Value $11.93M Shares 148,600 Share Price $80.29 Est. Cost/Share — Unrealized @ Report Date —
— Iterum Therapeutics 0.9%
Value $9.962M Shares 1,726,514 Share Price $5.77 Est. Cost/Share $10.89 Unrealized @ Report Date —
HALO Halozyme Therapeutics Inc 0.9%
Value $9.867M Shares 636,167 Share Price $15.51 * Est. Cost/Share $16.18 Unrealized @ Report Date +1.8%
TGTX TG Therapeutics Inc 0.9%
Value $9.734M Shares 1,733,628 Share Price $5.61 * Est. Cost/Share $6.96 Unrealized @ Report Date +0.1%
PTCT PTC Therapeutics Inc 0.9%
Value $9.715M Shares 287,245 Share Price $33.82 * Est. Cost/Share $39.49 Unrealized @ Report Date +10.2%
— Chiasma 0.7%
Value $8.07M Shares 1,630,221 Share Price $4.95 Est. Cost/Share $1.49 Unrealized @ Report Date —
SRPT Sarepta Therapeutics Inc 0.7%
Value $8.016M Shares 106,414 Share Price $75.33 * Est. Cost/Share $118.10 Unrealized @ Report Date 0.0%
— Kiniksa Pharmaceuticals, Ltd 0.7%
Value $7.852M Shares 922,700 Share Price $8.51 Est. Cost/Share $17.35 Unrealized @ Report Date —
MGNX MacroGenics Inc 0.7%
Value $7.421M Shares 581,554 Share Price $12.76 * Est. Cost/Share $16.83 Unrealized @ Report Date -14.4%
— Aimmune Therapeutics Inc 0.7%
Value $7.261M Shares 346,770 Share Price $20.94 Est. Cost/Share $20.94 Unrealized @ Report Date —
— Entasis Therapeutics Holdings Inc. 0.6%
Value $7.034M Shares 1,180,178 Share Price $5.96 Est. Cost/Share $10.88 Unrealized @ Report Date —
— Kadmon Holdings Inc 0.6%
Value $6.577M Shares 2,609,758 Share Price $2.52 Est. Cost/Share $2.74 Unrealized @ Report Date —
— Dermira Inc 0.6%
Value $6.327M Shares 990,168 Share Price $6.39 Est. Cost/Share $8.90 Unrealized @ Report Date —
— Beigene Ltd 0.6%
Value $6.123M Shares 50,000 Share Price $122.46 Est. Cost/Share — Unrealized @ Report Date —
— MyoKardia Inc 0.5%
Value $5.942M Shares 113,926 Share Price $52.16 Est. Cost/Share $52.16 Unrealized @ Report Date —
FATE Fate Therapeutics Inc 0.5%
Value $5.926M Shares 381,600 Share Price $15.53 * Est. Cost/Share $19.17 Unrealized @ Report Date 0.0%
FOLD Amicus Therapeutics Inc 0.5%
Value $5.798M Shares 722,974 Share Price $8.02 * Est. Cost/Share $12.56 Unrealized @ Report Date -13.6%
BMRN Biomarin Pharmaceutical Inc 0.5%
Value $5.722M Shares 84,896 Share Price $67.40 * Est. Cost/Share $87.63 Unrealized @ Report Date -12.1%
— Dicerna Pharmaceuticals Inc 0.4%
Value $4.923M Shares 342,755 Share Price $14.36 Est. Cost/Share $14.36 Unrealized @ Report Date —
AKBA Akebia Therapeutics Inc 0.4%
Value $4.811M Shares 1,227,191 Share Price $3.92 * Est. Cost/Share $5.75 Unrealized @ Report Date -25.5%
— Zymeworks Inc 0.4%
Value $4.672M Shares 188,438 Share Price $24.79 Est. Cost/Share $22.00 Unrealized @ Report Date —
XBIT XBiotech Inc 0.3%
Value $3.751M Shares 358,663 Share Price $10.46 * Est. Cost/Share $7.09 Unrealized @ Report Date -1.0%
— Foamix Pharmaceuticals Ltd 0.3%
Value $3.645M Shares 1,199,254 Share Price $3.04 Est. Cost/Share $4.42 Unrealized @ Report Date —
— Otonomy Inc 0.3%
Value $3.436M Shares 1,437,965 Share Price $2.39 Est. Cost/Share $2.80 Unrealized @ Report Date —
— Orchard Therapeutics PLC 0.3%
Value $3.367M Shares 283,406 Share Price $11.88 Est. Cost/Share $15.62 Unrealized @ Report Date —
— Forty Seven Inc 0.3%
Value $3.335M Shares 519,298 Share Price $6.42 Est. Cost/Share $7.38 Unrealized @ Report Date —
— Calithera Biosciences Inc 0.3%
Value $2.982M Shares 964,852 Share Price $3.09 Est. Cost/Share $3.53 Unrealized @ Report Date —
— ArQule Inc 0.3%
Value $2.82M Shares 393,387 Share Price $7.17 Est. Cost/Share $5.46 Unrealized @ Report Date —
— Homology Medicines Inc 0.2%
Value $2.647M Shares 146,297 Share Price $18.09 Est. Cost/Share $18.09 Unrealized @ Report Date —
CYTK Cytokinetics Inc 0.2%
Value $2.401M Shares 210,992 Share Price $11.38 * Est. Cost/Share $12.55 Unrealized @ Report Date 0.0%
— Mirati Therapeutics Inc 0.2%
Value $2.399M Shares 30,800 Share Price $77.89 Est. Cost/Share $77.89 Unrealized @ Report Date —
HRTX Heron Therapeutics Inc 0.2%
Value $2.283M Shares 123,400 Share Price $18.50 Est. Cost/Share $25.45 Unrealized @ Report Date -27.7%
ACRS Aclaris Therapeutics 0.2%
Value $2.064M Shares 1,911,573 Share Price $1.08 * Est. Cost/Share $19.07 Unrealized @ Report Date -92.6%
HRTX Heron Therapeutics Inc 0.2%
Value $1.917M Shares 103,602 Share Price $18.50 Est. Cost/Share $25.45 Unrealized @ Report Date -27.7%
— Kala Pharmaceuticals Inc 0.2%
Value $1.819M Shares 478,206 Share Price $3.80 Est. Cost/Share $5.38 Unrealized @ Report Date —
SNDX Syndax Pharmaceuticals Inc 0.2%
Value $1.817M Shares 243,150 Share Price $7.47 * Est. Cost/Share $6.52 Unrealized @ Report Date +39.6%
ALGN Align Technology Inc 0.2%
Value $1.81M Shares 10,000 Share Price $181.00 * Est. Cost/Share $207.89 Unrealized @ Report Date 0.0%
— Portola Pharmaceuticals Inc 0.1%
Value $1.588M Shares 59,191 Share Price $26.83 Est. Cost/Share $26.83 Unrealized @ Report Date —
— Applied Therapeutics Inc 0.1%
Value $1.56M Shares 142,004 Share Price $10.99 Est. Cost/Share $8.24 Unrealized @ Report Date —
— Syndax Pharmaceuticals Inc 0.1%
Value $1.494M Shares 200,000 Share Price $7.47 Est. Cost/Share — Unrealized @ Report Date —
BCRX BioCryst Pharmaceuticals Inc 0.1%
Value $1.481M Shares 516,734 Share Price $2.87 * Est. Cost/Share $5.51 Unrealized @ Report Date -43.5%
SVRA Savara Inc 0.1%
Value $1.397M Shares 527,318 Share Price $2.65 * Est. Cost/Share $2.50 Unrealized @ Report Date 0.0%
— Synlogic Inc. 0.1%
Value $1.317M Shares 574,972 Share Price $2.29 Est. Cost/Share $9.38 Unrealized @ Report Date —
APLS Apellis Pharmaceuticals, Inc 0.1%
Value $1.194M Shares 49,580 Share Price $24.08 * Est. Cost/Share $19.65 Unrealized @ Report Date +40.0%
— Heron Therapeutics Inc 0.1%
Value $995K Shares 53,800 Share Price $18.49 Est. Cost/Share — Unrealized @ Report Date —
— Sunesis Pharmaceuticals Inc 0.1%
Value $816K Shares 1,133,947 Share Price $0.72 Est. Cost/Share $0.72 Unrealized @ Report Date —
— Syndax Pharmaceuticals Inc 0.1%
Value $746K Shares 100,000 Share Price $7.46 Est. Cost/Share — Unrealized @ Report Date —
PDSB PDS Biotechnology Corporation 0.0%
Value $482K Shares 142,635 Share Price $3.38 * Est. Cost/Share $8.36 Unrealized @ Report Date -30.4%